Search results for

The annual PCT survey compares volumes of national-phase filings by firms in the world's largest jurisdictions. Below are the leading firms in this sector, together with arrows indicating the firms rising and falling

From October 1 2013, significant changes to trade mark procedures in the Benelux come into effect. The implementation of these modifications is the long-awaited result of intensive discussions, and further aligns procedures in the Benelux with those applied by OHIM for Community trade marks.

Whereas issues related to the patenting of inventions in the field of genetic engineering often give rise to discussions of morality and ethics, the same rarely holds true when it comes to patents in traditional fields of technology, such as machinery.

In a recent decision, the Austrian Supreme Court has confirmed its previous case law on the calculation of remuneration for employee inventions.

Might a preliminary injunction request be admitted if the patent on which it is grounded has been nullified by a court, but the court decision is being appealed? The Paris Appeal Court just answered positively (Cour d'Appel de Paris, May 23 2013, pôle 1, 2ème chambre).

The doctrine of estoppel has recently been codified into Article 6 of the Supreme Court's judicial interpretation No 21 [2009], which says a technical solution abandoned by the patentee or applicant through an amendment or a statement in the patent granting or invalidation procedure cannot be reclaimed into the scope of the patent. However, it is still unclear what kind of amendment or statement will constitute said "abandonment" of a technical solution, and thus trigger the application of the doctrine of estoppel. In a recent Supreme Court decision ((2011) Min Ti Z306), the Court set forth more specific rules for answering the above question.

US politicians and industry organisations urged President Barrack Obama to apply pressure on Indian Prime Minister Manmohan Singh over his country’s IP policies during Singh’s recent visit to the White House

Service providers are growing in size and power off the back of growth in PCT filings, among other areas. What are the costs and benefits of working with such ‘IP portals’ and how must patent attorneys adapt? Peter Leung reports

In practice, pharmaceutical patent infringement cases in Greece are usually over once injunction proceedings or main action proceedings relating to stopping the infringement are litigated. A recent judgment on royalties regarding infringement of a pharmaceutical patent containing process claims is therefore encouraging for pharmaceutical patent owners who are determined to pursue their case in every respect, including their right to sue for damages on the basis of royalties.

Simon Crompton talks to WIPO’s Carsten Fink about the future of the PCT system